Delivery Order SPE2DB22D1002-SPE2DB25FKYT1

Award Date 2/28/25
Potential Completion Date 3/3/25
Potential Value $1.7K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of TERIPARATIDE 600 MCG/2.4ML PEN 2.4ML. The contract has a ceiling value of $1,820.84 and a period of performance through February 21, 2025. This contract is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical, which serves as a primary vehicle...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,460.54, is for the delivery of teriparatide 600 mcg/2.4 ml pens to support military healthcare programs. The contract is a Firm Fixed Price Delivery Order with a period of performance through February 4, 2025. There is no set-aside designation indicated for this award. AmerisourceBergen holds a...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,564,630,664 units of teriparatide 600 mcg/2.4 ml pen 2.4 ml, a specialty medication used in the treatment of certain medical conditions. The contract has a firm fixed price of $7,705.99 and a performance period ending on May 17, 2024. AmerisourceBergen holds a significant...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major supplier of pharmaceutical products and medical supplies to the U.S. federal government. The contract, valued at $2,591.28, is for the delivery of teriparatide 600 mcg/2.4 ml pens. The contract is a firm fixed-price delivery order that was awarded without the use of a set-aside. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with DLA Troop...
This federal contract award is to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the delivery of Teriparatide 600 mcg/2.4 ml pens. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for $2,591.28. The order is for 4,565,250,079 units of teriparatide 600 mcg/2.4 ml pen with a 2.4 ml capacity. The order has a firm fixed price and a completion date of July 26, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical to provide a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the delivery of 4,564,464,842 units of Teriparatide 600 mcg/2.4 ml pen, 2.4 ml. The contract is a firm fixed-price delivery order with a ceiling value of $8,225.76 and an ultimate completion date of May 2, 2024. This award is associated with a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $29,830.25 firm fixed-price delivery order is for the supply of 4,566,054,436 units of the drug Teriparatide 600 mcg/2.4 ml pen. The contract has an ultimate completion date of October 9, 2024. This award is associated with a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at up to...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $11,460.44 firm fixed price delivery order is for the supply of Teriparatide 600 mcg/2.4ml pen 2.4ml, a specialty medication. The contract has an ultimate completion date of November 4, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a...
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract is for the delivery of 4,567,197,739 units of the medication teriparatide 620 mcg/2.48 ml, with a total ceiling value of $2,146.66. The contract is a firm fixed-price delivery order with a completion date of February 7, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop...
  • SPE2DB22D1002
    Indefinite Delivery Contract
  • SPE2DB22D1002-SPE2DB25FKYT1
    Delivery Order

This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Teriparatide 600 mcg/2.4 ml pens. The contract has a ceiling value of $1,746.58 and runs through March 3, 2025. It is a Firm Fixed Price contract with no set-aside designation.

AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical worth $999,999,999 through November 2026. This IDC serves as a primary vehicle for the company to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract encompasses critical medical commodities across multiple therapeutic areas.

Generated 5/30/25, 10:12 AM